Clinical Trials in Maryland

Showing 4801-4820 of 17,687 trials

Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy

NCT02633943

This is a multi-center, long-term safety and efficacy follow-up study for subjects with transfusion-dependent β-thalassemia (TDT) who have been treated with ex vivo gene therapy drug product in bluebird bio-sponsored parent clinical studies. After completing the parent clinical studies (approximately 2 years), eligible subjects will be followed for an additional 13 years for a total of 15 years post-drug product infusion. No investigational drug product will be administered in this study.

Transfusion-dependent Beta-Thalassemia

Genetix Biotherapeutics Inc.66 participantsStarted Jan 2014

Oakland, California, United States • Chicago, Illinois, United States • Bethesda, Maryland, United States +12 more locations

TERMINATEDPhase 317 miles

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

NCT03192215

Objectives * Primary: To test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in patients with cryptogenic ischemic stroke and atrial cardiopathy. * Secondary: To test the hypothesis that the relative efficacy of apixaban over aspirin increases with the severity of atrial cardiopathy.

Stroke

Columbia University1,015 participantsStarted Jan 2018

Birmingham, Alabama, United States • Mobile, Alabama, United States • Chandler, Arizona, United States +174 more locations

Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

Find Trials by Condition in Maryland

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

Working Memory and Physical Exercise Training in Patients With Mild Cognitive Impairment

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

A Spatial Analysis of Hotspots and Targeted Injection Settings Pilot Intervention for HIV Prevention Among People Who Inject Drugs

Effects of RAS on Gait in PD Patients With DBS

Multimodel Exercise and Weight Loss in Older Obese Veterans With Dysmobility

Study of ASTX295 in Patients With Solid Tumors With Wild-Type p53

A Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System (SUMMIT MAX)

Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

A Phase 3 Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE)

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

Calypso Knee System Clinical Study

FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)

Amivantamab in Adenoid Cystic Carcinoma

Study to Evaluate the Efficacy of a Probiotic in Infantile Colic Symptoms Relief

A Bioequivalence Study of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection Using an Autoinjector in Healthy Study Participants